Page last updated: 2024-12-06

flutonidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Flutonidine is a selective alpha-2 adrenergic receptor agonist. It is an experimental drug that has been studied for its potential therapeutic effects in a variety of conditions, including hypertension, migraine headaches, and attention deficit hyperactivity disorder (ADHD). Flutonidine is thought to exert its effects by stimulating alpha-2 adrenergic receptors in the central nervous system, leading to a reduction in sympathetic nervous system activity. Research on flutonidine is ongoing, and its potential therapeutic uses are still being investigated.'

flutonidine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65761
CHEMBL ID2106760
SCHEMBL ID352837
MeSH IDM0055574

Synonyms (24)

Synonym
5-fluoro-2-methylimidazolidinylidenebenzamine
2-(5-fluoro-o-toluidino)-2-imidazoline
flutonidinum [inn-latin]
flutonidina [inn-spanish]
flutonidine
st 600
flutonidine [inn]
n-(5-fluoro-2-methylphenyl)-4,5-dihydro-1h-imidazol-2-amine
st-600
28125-87-3
AKOS006273430
flutonidina
unii-zcc19f3x8k
zcc19f3x8k ,
flutonidinum
CHEMBL2106760
SCHEMBL352837
n-(5-fluoro-2-methylphenyl)-2-imidazolidineimine
DTXSID90182405
2-[(5-fluoro-2-methyl-phenyl)imino]imidazolidine
BCP33057
flutonidinum; st600; st-600; st 600
Q27295304
EN300-738519

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Analysis of the dose-response curves demonstrated that the effect of flutonidin was one-fifth to one-twelfth that of clonidine, depending on which variable was considered."( Hypotensive action and side-effects of flutonidin in normal subjects. A double-blind controlled trial.
Chierichetti, SM; Ferrari, P; Sala, P, 1979
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID227718Binding energy by using the equation deltaG obsd = -RT ln KD1984Journal of medicinal chemistry, Dec, Volume: 27, Issue:12
Functional group contributions to drug-receptor interactions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (17.65%)5.53%
Reviews1 (5.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (76.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]